Zahra Rattray

Zahra Rattray is a Reader in Translational Pharmaceutics at the University of Strathclyde's Strathclyde Institute of Pharmacy and Biomedical Sciences. She serves as Director of the EPSRC Multiscale Metrology Suite for Next-Generation Health Nanotechnologies and leads a research team focused on drug delivery systems and cancer therapeutics. Her affiliations include roles in the Royal Pharmaceutical Society, Academy of Pharmaceutical Sciences, and RSE Young Academy of Scotland.

Education:

• Master of Pharmacy (University of Manchester, 2008)
• PhD in Pharmaceutical Image Analysis (University of Strathclyde, 2013)
• Postgraduate Certificate in Academic Practice (University of Strathclyde, 2021)

Research Interests: Zahra’s work spans two core areas: (1) Characterization of nanomedicines and parenteral formulations using advanced techniques like field flow fractionation, and (2) Development of DNA repair agents and nuclear import pathway inhibitors for cancer treatment. Her lab employs cutting-edge tools such as the NanoSight NS300 and LCMS-2050 for particle analysis and metabolomics.

Publications & Awards: With 108 peer-reviewed articles and 21 awards, her contributions include the Academy of Pharmaceutical Sciences Emerging Scientist Award (2023) and recognition in the Saltire Scotland 40 Under 40 List. She chairs the Advanced Therapy Medicinal Products focus group and serves on EPSRC peer review panels.

Grants & Outreach: Zahra leads 49 research projects, including EPSRC-funded initiatives on nanoparticle delivery and metabolomics. She collaborates with NHS Lanarkshire on patient engagement programs and champions diversity in STEM through outreach activities.